Detalhe da pesquisa
1.
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.
Blood
; 142(18): 1518-1528, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506339
2.
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031761
3.
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma.
J Thromb Thrombolysis
; 55(3): 464-473, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630029
4.
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.
Blood
; 136(2): 199-209, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325491
5.
Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease.
Blood
; 133(25): 2664-2668, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010846
6.
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.
Blood
; 134(16): 1337-1345, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484647
7.
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Blood
; 138(19): 1901-1905, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329372
8.
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma.
Blood
; 128(4): 497-503, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226434
9.
Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy.
Hematol Oncol
; 36(1): 316-319, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28580733
10.
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
Blood
; 126(7): 858-62, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26089396
11.
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.
Hematol Oncol
; 35(4): 746-751, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605156
12.
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.
Cancers (Basel)
; 16(9)2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730641
13.
Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA study.
Br J Haematol
; 163(5): 581-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24117042
14.
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma.
Front Oncol
; 13: 1197340, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023148
15.
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.
Cancers (Basel)
; 15(11)2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296925
16.
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.
Blood Adv
; 6(11): 3234-3239, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157768
17.
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.
Blood Cancer J
; 12(4): 76, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468898
18.
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
Cancers (Basel)
; 14(20)2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291952
19.
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.
J Clin Oncol
; 40(27): 3151-3161, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35666958
20.
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 22(9): e844-e852, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688793